Centralised Pan-European Survey on the Undertreatment of Hyperchlesterolemia - CEPHEUS
- Conditions
- Patients on lipid-lowering pharmacological treatment
- Registration Number
- EUCTR2006-000954-31-FI
- Lead Sponsor
- AstraZeneca Oy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20900
Inclusion Criteria
-Subject must be 18 years of age or older of either sex and of any race.
-Subject must demonstrate his/her willingness to participate in the survey and comply with its procedures by signing a written informed consent.
-Subject is on lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
-Subjects who are unwilling or unable to provide informed consent.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method